Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Johnson

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Neuro-Oncology|May 10, 2017
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancerAmanda E D Van Swearingen, Maria J Sambade, Marni B Siegel, et al.
ACS Medicinal Chemistry Letters|June 5, 2012
Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic LeukemiaJing Liu, Chao Yang, Catherine Simpson, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Plos One|July 5, 2013
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemiaMatthew J Cooper, Nathan J Cox, Eric I Zimmerman, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Breast Cancer Research and Treatment|December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancerVishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Cancer Discovery|December 5, 2024
Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic ApproachesYi Xu, Xianlu L Peng, Michael P East, et al.
Cell Reports|April 14, 2015
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family BromodomainsTimothy J Stuhlmiller, Samantha M Miller, Jon S Zawistowski, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Neuro-Oncology|May 10, 2017
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancerAmanda E D Van Swearingen, Maria J Sambade, Marni B Siegel, et al.
ACS Medicinal Chemistry Letters|June 5, 2012
Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic LeukemiaJing Liu, Chao Yang, Catherine Simpson, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Plos One|July 5, 2013
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemiaMatthew J Cooper, Nathan J Cox, Eric I Zimmerman, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Breast Cancer Research and Treatment|December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancerVishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Cancer Discovery|December 5, 2024
Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic ApproachesYi Xu, Xianlu L Peng, Michael P East, et al.
Cell Reports|April 14, 2015
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family BromodomainsTimothy J Stuhlmiller, Samantha M Miller, Jon S Zawistowski, et al.
Pageof 18